DHL Supply Chain strengthens its presence in Mexico
DHL Supply Chain has acquired NTA – New Transport Applications – a company specialized in providing logistics services to the pharmaceutical and healthcare sector.
With more than 20 years of experience in the Mexican market, NTA is a recognized industry player serving more than 80 customers with services that include the storage and transportation of products that require refrigeration and temperature control.
With this acquisition, DHL Supply Chain will continue to strengthen its position and operating capacity in the high potential industry sector thanks to NTA’s know-how, experience and coverage throughout the country.
“This acquisition will further support DHL Supply Chain’s objectives of delivering superior value to our customers in the Mexican market. It will significantly bolster our footprint in a strategically important industry vertical for DHL globally, bringing together NTA’s proven operational capabilities, know-how and a team of healthcare experts. We expect to unlock significant growth opportunities for our customers and people”, said Agustin Croche, President of DHL Supply Chain Mexico.
Currently, NTA makes more than 165,000 specialized deliveries annually, distributing more than 43,000 tons per year under the highest quality standards with a team of nearly 600 people that are always close to its customers. It maintains commercial agreements with all major airlines in Mexico to serve nationally the different stakeholders in the pharmaceutical product supply chain, including hospitals, sales representatives, pharmacies, and patients.
“Becoming part of DHL Supply Chain is a significant and positive milestone in NTA’s history and recognition of the great team of people who drive this company since our foundation 20 years ago, We hope to merge our knowledge of the local market and experience in managing the cold chain with the resources and skills of the world leader in logistics for the benefit of our people and our customers.” said Rafael Figueroa, General Director of NTA.
Mexico is the second largest pharmaceutical market in Latin America and shares a border and free trade agreement with the United States, the largest healthcare market globally. In August 2022, the National Chamber of the Pharmaceutical Industry of Mexico (Canifarma) forecasted growth of 36% in pharmaceutical production in 2022, the first year of double-digit growth within the last decade. Investments from international pharmaceutical companies are expected to increase.
